Login / Signup
Zixiang Gong
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Cell Cycle Arrest
Pluripotent Stem Cells
Diabetic Rats
Dna Damage Response
Top Venues
Metabolic brain disease
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Wang Chen
,
Pida Hao
,
Xiaotong Feng
,
Xiaotong Feng
,
Xuan Zhao
,
Jincheng Wu
,
Zixiang Gong
,
Jinli Zhang
,
Xiao-Yan Fu
,
Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis.
Metabolic brain disease
39 (4) (2024)
Wang Chen
,
Pida Hao
,
Xiaotong Feng
,
Xiaotong Feng
,
Xuan Zhao
,
Jincheng Wu
,
Zixiang Gong
,
Jinli Zhang
,
Xiao-Yan Fu
,
Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis.
Metabolic brain disease
(2024)
Wang Chen
,
Pida Hao
,
Xiaotong Feng
,
Xiaotong Feng
,
Xuan Zhao
,
Jincheng Wu
,
Zixiang Gong
,
Jinli Zhang
,
Xiao-Yan Fu
,
Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis.
Metabolic brain disease
39 (4) (2024)
Wang Chen
,
Pida Hao
,
Xiaotong Feng
,
Xiaotong Feng
,
Xuan Zhao
,
Jincheng Wu
,
Zixiang Gong
,
Jinli Zhang
,
Xiao-Yan Fu
,
Xianjun Wang
Methylseleninic acid inhibits human glioma growth in vitro and in vivo by triggering ROS-dependent oxidative damage and apoptosis.
Metabolic brain disease
39 (4) (2024)